Iodobenzamide
Chemical compound
Iodobenzamide is a chemical compound that is primarily used in the field of nuclear medicine as a radiolabeled imaging agent. It is a derivative of benzamide and contains an iodine atom, which is crucial for its application in medical imaging.
Chemical Structure
Iodobenzamide is characterized by the presence of an iodine atom attached to the benzamide moiety. The chemical structure can be represented as a benzene ring with an amide group and an iodine substituent. This structure allows it to be used as a ligand in various imaging techniques.
Applications in Nuclear Medicine
Iodobenzamide is commonly used in single-photon emission computed tomography (SPECT) imaging. It is often labeled with the radioactive isotope iodine-123 (I-123) to create a radiopharmaceutical known as I-123 iodobenzamide (IBZM). This radiopharmaceutical is used to image the dopamine receptors in the brain, particularly the D2 receptors.
Dopamine Receptor Imaging
The ability of iodobenzamide to bind to dopamine receptors makes it valuable in the diagnosis and study of various neurological disorders. It is particularly useful in the assessment of Parkinson's disease and other conditions that affect the dopaminergic system. By visualizing the distribution and density of dopamine receptors, clinicians can gain insights into the functioning of the brain's dopaminergic pathways.
Synthesis
The synthesis of iodobenzamide involves the iodination of benzamide derivatives. This process typically requires the use of iodine or iodine-containing reagents to introduce the iodine atom into the benzamide structure. The specific conditions and reagents used can vary depending on the desired isotopic labeling and the intended application of the compound.
Safety and Handling
As with many radiopharmaceuticals, the handling of iodobenzamide, especially when labeled with radioactive isotopes, requires strict adherence to safety protocols. Proper shielding, handling, and disposal procedures must be followed to minimize exposure to radiation.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD